C.R. Bard, Inc. (NYSE:BCR)

CAPS Rating: 4 out of 5

The Company is engaged in the design, manufacture, packaging, distribution and sale of medical, surgical, diagnostic and patient care devices.

Recs

0
Player Avatar pedromigz (26.30) Submitted: 9/4/2009 7:18:28 AM : Outperform Start Price: $78.89 BCR Score: -4.97

BofD, z3, pt92, analrep

Report this Post Reply

Featured Broker Partners


Advertisement